ROSLEA SURGERY — All Prescriptions & Medications — Page 10
Practice Code: P81083 | PRESTON, PR5 6PE
Showing results 451-500 of 571
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hypromellose | 18 | 190 | £20 | -86.4% ▼ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 18 | 18 | £253 | -84.1% ▼ |
| Fluocinolone acetonide | 18 | 930 | £150 | +65.3% ▲ |
| 18 | 1,350 | £109 | +83.7% ▲ | |
| 18 | 470 | £1.2K | +95.5% ▲ | |
| 18 | 320 | £689 | +107.6% ▲ | |
| Propafenone hydrochloride | 17 | 2,462 | £225 | +57.0% ▲ |
| Naratriptan hydrochloride | 17 | 102 | £20 | -35.0% ▼ |
| Phenobarbital | 17 | 1,036 | £207 | -44.7% ▼ |
| Testosterone esters | 17 | 17 | £40 | +15.3% ▲ |
| Cabergoline | 17 | 216 | £390 | +9.6% ▲ |
| Degarelix | 17 | 17 | £2.2K | -2.0% ▼ |
| Ciprofloxacin | 17 | 285 | £109 | +84.4% ▲ |
| Other toiletry preparations | 17 | 7,300 | £88 | -60.2% ▼ |
| 17 | 1,850 | £371 | -34.1% ▼ | |
| 17 | 510 | £1.1K | +20.1% ▲ | |
| Sodium citrate (Rectal) | 16 | 283 | £184 | +16.0% ▲ |
| Biphasic insulin aspart | 16 | 80 | £478 | -84.2% ▼ |
| Estradiol valerate | 16 | 1,176 | £98 | -18.1% ▼ |
| Alprostadil | 16 | 56 | £602 | -6.4% ▼ |
| Tube feed 2 kcal/ml with fibre (0914011) | 16 | 427.0K | £10.3K | +50.9% ▲ |
| Pimecrolimus | 16 | 690 | £430 | -5.5% ▼ |
| Clindamycin phosphate | 16 | 600 | £120 | -2.7% ▼ |
| 16 | 37 | £219 | -9.8% ▼ | |
| 16 | 66 | £379 | +25.8% ▲ | |
| 16 | 26 | £3.3K | -55.2% ▼ | |
| 16 | 1,460 | £215 | -60.9% ▼ | |
| Glyceryl trinitrate | 15 | 450 | £560 | +12.9% ▲ |
| Clonidine hydrochloride | 15 | 732 | £57 | -17.9% ▼ |
| Levodopa/carbidopa/entacapone | 15 | 1,140 | £752 | -46.4% ▼ |
| Erythromycin ethylsuccinate | 15 | 1,868 | £372 | -35.8% ▼ |
| Soluble insulin (Neutral insulin) | 15 | 65 | £303 | +55.7% ▲ |
| Water for injection | 15 | 170 | £67 | -55.7% ▼ |
| Betamethasone sodium phosphate | 15 | 160 | £41 | -42.1% ▼ |
| Olopatadine | 15 | 75 | £76 | -65.8% ▼ |
| Azelaic acid | 15 | 720 | £157 | -37.3% ▼ |
| 15 | 660 | £88 | -49.8% ▼ | |
| 15 | 2,300 | £21 | -40.4% ▼ | |
| 15 | 3,200 | £139 | -60.7% ▼ | |
| 15 | 41 | £853 | +47.1% ▲ | |
| 15 | 1,230 | £3.9K | +17.4% ▲ | |
| 15 | 960 | £197 | +44.1% ▲ | |
| Terazosin hydrochloride | 14 | 476 | £101 | -13.9% ▼ |
| Valsartan | 14 | 728 | £177 | -76.2% ▼ |
| Lofepramine hydrochloride | 14 | 1,242 | £614 | -53.2% ▼ |
| Tetrabenazine | 14 | 3,780 | £513 | -11.7% ▼ |
| Acamprosate calcium | 14 | 2,184 | £250 | -59.8% ▼ |
| Canagliflozin | 14 | 398 | £495 | -90.2% ▼ |
| Betamethasone sodium phosphate | 14 | 730 | £96 | +13.9% ▲ |
| Combined ethinylestradiol 35mcg | 14 | 2,268 | £159 | +12.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.